Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Prospectively, economic studies must evaluate whether earlier intervention might enhance cost-effectiveness by preventing dropout and improving long-term adherence among GLP-1 agonist non-responders
A strong PBM partner should help you evaluate both the clinical value and financial impact so you can determine the right approach for your plan
Ajani JA, DAmico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al
They cannot just disappear overnight
The drug is being developed by Eli Lilly and Company and remains under active investigation
GLP-1 receptor agonists like Ozempic (semaglutide) and Mounjaro (tirzepatide) have revolutionized diabetes management and weight loss treatment
US$ 29.18
US$ 22.75
US$ 29.54
US$ 26.46
US$ 29.73
